Type 2 diabetes and cardiovascular disease: getting to the fat of the matter

Author： Goralski Kerry B. Sinal Christopher J.

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.85, Iss.1, 2007-01, pp. : 113-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

By Saylor Philip J.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite

Use of medications for cardiovascular disease and type 2 diabetes mellitus is reduced after bariatric surgery for weight management in patients with severe obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease

By Gude AB J Christiansen J S

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1603-1604

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer's Disease and Type 2 Diabetes: What Is the Connection?

The Consultant Pharmacist, Vol. 30, Iss. 2, 2015-02 ,pp. : 112-115

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Preventing cardiovascular disease in diabetes

By Harvey John N.

Clinical Medicine, Vol. 4, Iss. 4, 2004-07 ,pp. : 311-314

Royal College Of Physicians

Access to resources Recommend Favorite